Itron, Inc. (NASDAQ:ITRI) Shares Sold by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. decreased its position in Itron, Inc. (NASDAQ:ITRI - Free Report) by 27.0% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 14,884 shares of the scientific and technical instruments company's stock after selling 5,503 shares during the period. Oppenheimer & Co. Inc.'s holdings in Itron were worth $1,559,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. GeoWealth Management LLC lifted its position in shares of Itron by 4,580.0% during the 4th quarter. GeoWealth Management LLC now owns 234 shares of the scientific and technical instruments company's stock valued at $25,000 after buying an additional 229 shares in the last quarter. Proficio Capital Partners LLC purchased a new position in Itron during the fourth quarter valued at $30,000. CoreCap Advisors LLC grew its position in shares of Itron by 25.5% in the fourth quarter. CoreCap Advisors LLC now owns 616 shares of the scientific and technical instruments company's stock valued at $67,000 after purchasing an additional 125 shares during the period. Smartleaf Asset Management LLC grew its position in shares of Itron by 347.5% in the fourth quarter. Smartleaf Asset Management LLC now owns 886 shares of the scientific and technical instruments company's stock valued at $97,000 after purchasing an additional 688 shares during the period. Finally, Contravisory Investment Management Inc. increased its stake in shares of Itron by 98.0% during the first quarter. Contravisory Investment Management Inc. now owns 1,711 shares of the scientific and technical instruments company's stock worth $179,000 after purchasing an additional 847 shares in the last quarter. Hedge funds and other institutional investors own 96.19% of the company's stock.

Itron Trading Up 0.7%

Shares of Itron stock traded up $0.94 during mid-day trading on Tuesday, hitting $132.57. The stock had a trading volume of 449,916 shares, compared to its average volume of 560,869. The firm has a 50-day moving average of $117.56 and a two-hundred day moving average of $109.02. The firm has a market cap of $6.04 billion, a P/E ratio of 24.19, a price-to-earnings-growth ratio of 0.83 and a beta of 1.35. The company has a quick ratio of 1.65, a current ratio of 1.93 and a debt-to-equity ratio of 0.52. Itron, Inc. has a 12-month low of $90.11 and a 12-month high of $134.52.

Itron (NASDAQ:ITRI - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The scientific and technical instruments company reported $1.52 EPS for the quarter, beating analysts' consensus estimates of $1.30 by $0.22. The firm had revenue of $607.15 million for the quarter, compared to analysts' expectations of $608.86 million. Itron had a return on equity of 19.65% and a net margin of 10.34%. The firm's quarterly revenue was up .6% on a year-over-year basis. During the same period in the prior year, the firm posted $1.24 earnings per share. Sell-side analysts forecast that Itron, Inc. will post 5.33 earnings per share for the current year.

Insider Buying and Selling at Itron

In other news, Director Mary C. Hemmingsen sold 5,150 shares of the company's stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $108.70, for a total value of $559,805.00. Following the transaction, the director directly owned 952 shares in the company, valued at approximately $103,482.40. This represents a 84.40% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP Donald L. Reeves III sold 529 shares of the stock in a transaction that occurred on Tuesday, May 27th. The stock was sold at an average price of $114.95, for a total transaction of $60,808.55. Following the transaction, the senior vice president directly owned 20,151 shares of the company's stock, valued at $2,316,357.45. The trade was a 2.56% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 20,905 shares of company stock worth $2,439,202. Insiders own 1.51% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the stock. Guggenheim reaffirmed a "buy" rating and issued a $133.00 price target on shares of Itron in a research note on Thursday, April 17th. TD Cowen raised their target price on Itron from $139.00 to $145.00 and gave the company a "buy" rating in a research report on Friday, June 20th. Piper Sandler dropped their price target on Itron from $124.00 to $121.00 and set a "neutral" rating for the company in a research report on Monday, May 5th. Finally, Wall Street Zen cut shares of Itron from a "buy" rating to a "hold" rating in a research note on Sunday, June 1st. Four analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat, Itron presently has a consensus rating of "Moderate Buy" and an average price target of $128.18.

Itron Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.